lisuride has been researched along with Dyskinesia, Drug-Induced in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (36.84) | 18.7374 |
1990's | 9 (47.37) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerlach, M; Reichmann, H; Riederer, P | 1 |
Marsden, CD; Parkes, JD; Schachter, M; Smith, B; Wilson, A | 1 |
Gerlach, J; Peacock, L | 1 |
Cesaro, P; Hantraye, P; Maziere, M; Peschanski, M; Riche, D; Varastet, M; Willer, JC | 1 |
Barbato, L; Berardelli, A; Bonamartini, A; Manfredi, M; Patsalos, PN; Ruggieri, S; Stocchi, F | 1 |
Brotchie, JM; Crossman, AR; Henry, B | 1 |
Clarke, CE; Speller, JM | 2 |
Filip, V; Hálková, E; Karen, P; Marsálek, M | 1 |
Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J | 1 |
Baronti, F; Brughitta, G; Chase, TN; Conant, KE; Giuffra, M; Mouradian, MM | 1 |
Heinz, A; Klewin, I; Klotz, P; Kuhn, W; Przuntek, H; Suchy, I | 1 |
Genitrini, S; Giovannini, P; Girotti, F; Piccolo, I; Scigliano, G; Suchy, I; Testa, D | 1 |
Luquin, MR; Martînez Lage, JM; Obeso, JA; Vaamonde, J | 1 |
Critchley, PH; Grandas Perez, F; Marsden, CD; Parkes, JD; Quinn, NP | 1 |
García, S; Gershanik, OS; Scipioni, O | 1 |
Horowski, R; Marsden, CD; Obeso, JA | 1 |
Luquin, MR; Martínez Lage, JM; Obeso, JA | 2 |
3 review(s) available for lisuride and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
Lisuride for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
Continuous dopaminergic stimulation: state of the art and outlook.
Topics: Antiparkinson Agents; Apomorphine; Dopamine; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Infusion Pumps; Lisuride; Mental Disorders; Movement; Neurology; Parkinson Disease; Stimulation, Chemical | 1988 |
1 trial(s) available for lisuride and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Treatment of extrapyramidal side effects with terguride.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
15 other study(ies) available for lisuride and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Levodopa in the treatment of Parkinson's disease: current controversies.
Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide | 2005 |
Lisuride in parkinsonism.
Topics: Administration, Oral; Aged; Benzimidazoles; Chorea; Domperidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Growth Hormone; Humans; Injections, Intravenous; Lisuride; Male; Middle Aged; Paralysis; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Piperidines; Prolactin | 1981 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.
Topics: Animals; Behavior, Animal; Blinking; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Electromyography; Electrophysiology; Female; Immunohistochemistry; Lisuride; Male; Mesencephalon; MPTP Poisoning; Nerve Fibers; Papio; Parkinson Disease, Secondary; Postural Balance; Posture; Tremor | 1993 |
Clinical implications of sustained dopaminergic stimulation.
Topics: Aged; Benserazide; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Lisuride; Parkinson Disease; Reaction Time | 1994 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Sulpiride | 1992 |
Partial dopamine agonist therapy of levodopa-induced dyskinesias.
Topics: Adult; Aged; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Middle Aged; Movement | 1992 |
Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Injections, Subcutaneous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Psychomotor Performance | 1992 |
Terguride in the treatment of Parkinson disease: preliminary experience.
Topics: Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1990 |
Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease.
Topics: Drug Eruptions; Dyskinesia, Drug-Induced; Equipment Failure; Ergolines; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Lisuride; Male; Mental Disorders; Movement; Movement Disorders; Parkinson Disease; Platelet Aggregation | 1988 |
Continuous subcutaneous lisuride infusions in Parkinson's disease.
Topics: Adult; Aged; Drug Eruptions; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Hypotension; Infusion Pumps; Lisuride; Male; Mental Disorders; Middle Aged; Movement; Parkinson Disease | 1988 |
Lisuride infusion pump in Parkinson's disease. A report of two cases.
Topics: Aged; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Lisuride; Mental Disorders; Parkinson Disease | 1988 |
Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Topics: Adult; Aged; Domperidone; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Injections, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
[Oral lisuride in Parkinson's disease].
Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |